- Home
- MGNI vs RXRX Comparison
MGNI vs RXRX Comparison
Compare MGNI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGNI
- RXRX
- Stock Information
- Founded
- MGNI 2007
- RXRX 2013
- Country
- MGNI United States
- RXRX United States
- Employees
- MGNI N/A
- RXRX N/A
- Industry
- MGNI Computer Software: Programming Data Processing
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MGNI Technology
- RXRX Health Care
- Exchange
- MGNI Nasdaq
- RXRX Nasdaq
- Market Cap
- MGNI 3.1B
- RXRX 2.6B
- IPO Year
- MGNI N/A
- RXRX 2021
- Fundamental
- Price
- MGNI $18.64
- RXRX $5.87
- Analyst Decision
- MGNI Strong Buy
- RXRX Buy
- Analyst Count
- MGNI 11
- RXRX 4
- Target Price
- MGNI $26.18
- RXRX $7.25
- AVG Volume (30 Days)
- MGNI 2.4M
- RXRX 71.4M
- Earning Date
- MGNI 11-05-2025
- RXRX 11-05-2025
- Dividend Yield
- MGNI N/A
- RXRX N/A
- EPS Growth
- MGNI N/A
- RXRX N/A
- EPS
- MGNI 0.29
- RXRX N/A
- Revenue
- MGNI $685,074,000.00
- RXRX $64,596,000.00
- Revenue This Year
- MGNI $2.82
- RXRX $24.17
- Revenue Next Year
- MGNI $11.65
- RXRX $20.96
- P/E Ratio
- MGNI $65.39
- RXRX N/A
- Revenue Growth
- MGNI 5.52
- RXRX 30.14
- 52 Week Low
- MGNI $8.22
- RXRX $3.79
- 52 Week High
- MGNI $26.65
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- MGNI 40.36
- RXRX 51.99
- Support Level
- MGNI $18.45
- RXRX $5.58
- Resistance Level
- MGNI $20.35
- RXRX $6.50
- Average True Range (ATR)
- MGNI 0.85
- RXRX 0.61
- MACD
- MGNI 0.26
- RXRX -0.04
- Stochastic Oscillator
- MGNI 52.63
- RXRX 37.91
About MGNI Magnite Inc.
Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.